Researchers at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and collaborators from the School of Basic Medical Sciences, Fudan University, Shanghai, have developed an 'intravenous injection plus light-triggered intraocular drug release' strategy to achieve drug accumulation in retinoblastoma.